SEFAP calls for using every visit in Primary Care to review and ensure adherence to treatment

SEFAP asks to take advantage of every visit in Primary Care to detect barriers and reinforce therapeutic adherence through dialogue and continuous monitoring.

Add DEMÓCRATA to Google

Ask FREN

Published

3 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 19 de noviembre de 2026 · 18 institutos

  • PP31,1 %
  • PSOE27,4 %
  • Vox19,1 %
  • Frente Amplio6,2 %
  • ERC2,5 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

The president of the Sociedad Española de Farmacéuticos de Atención Primaria (SEFAP), Mercedes Pereira, has called on people to make use of every encounter with the patient in Primary Care (AP) to listen, without judgment, to their medication routines, detect possible obstacles, and address them in order to ensure therapeutic adherence.

Pereira has stressed that adherence "is not a result that can be taken as established after a consultation nor is it a fixed quality of the patient or a responsibility solely on their part, since the relationship with medication evolves over a lifetime."

As she explained, there are patients who begin treatment convinced and, after some time, modify their doses due to the appearance of an adverse effect, a new concern, an economic problem, or a family change, while others do not consider it important to comment that they skip some doses when they leave home. In all these cases, she insisted that none of these situations "should be interpreted without talking with the person."

In this context, she highlighted the longitudinal nature of Primary and Community Care, which makes it easier to observe the patient’s progress: from the emergence of doubts about a regimen that was previously straightforward, to the point where a person who used to come alone starts going accompanied, or where a usual dispensing begins to become more spaced out.

"Family medicine, nursing, Primary Care pharmacy, and community pharmacy provide different observations. Sharing them, with responsibilities and clear pathways, makes it possible to understand the problem before limiting oneself to labeling the patient as 'non-adherent,'" she said.

Along these lines, she warned that mere continuity of care is not enough, and she emphasized the need to "take advantage of every contact to listen, verify the information, and address specific barriers."

Importance of dialogue and of the relationship of trust

Regarding the instruments available to assess adherence, Pereira expressed reservations about those that are based solely on what the patient states, since they tend to overestimate treatment compliance compared with other methods and may induce a false sense of security.

As an alternative, she has defended frank conversation and the building of a relationship of trust. "Questionnaires and dispensing data help detect signals, but only conversation and follow-up allow one to understand what is happening and act," she said.

The recommendations of the National Institute for Health and Care Excellence (NICE) of the United Kingdom advise systematically reviewing adherence, without blaming, through open questions, specific time periods, and by addressing both practical problems and the patient’s concerns.

Following this approach, the president of SEFAP has proposed replacing questions such as "Do you take your medication properly?" with others like "In the last few weeks, what treatment has been most difficult for you to keep up with?", "Has anything changed since we last spoke?" or "What do you do when you think a medication makes you feel unwell?".

In addition, she has emphasized that this process is not resolved in a single appointment, but rather requires a prolonged relationship of trust. "It’s not only whether the patient takes their medication today: the issue is what they need in order to be able to continue using it safely tomorrow, in six months, and when their life changes. That question demands time, coordination, and a Primary Care team capable of remembering the entire story," she stressed.

Finally, Pereira has highlighted the relevance of the Primary Care pharmacist in addressing therapeutic adherence in complex outpatients. She believes this professional is in an ideal position to integrate information coming from different prescribers and dispensings, detect problems associated with the regimen or adverse effects, and collaborate with the rest of the team to optimize pharmacotherapy, provide the patient with a coherent message about their treatment, and carry out follow-up to confirm whether the measures adopted are effective.